MIR-155 INHIBITORS FOR TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (CTCL) Russian patent published in 2020 - IPC C12N15/113 A61P35/00 

Abstract RU 2718534 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to the biotechnology. Described is an oligonucleotide miR-155 inhibitor containing/consisting of sequence (s) and 5’-lCs.dAs.lCs.dGs.dAs.lTs.lTs.dAs.lGs.dCs.lAs.lTs.lTs.lA-3’ (SEQ ID NO: 25), where l is a closed nucleotide; d is a deoxyribonucleotide; s is a phosphorothioate bond or an oligonucleotide miR-155 inhibitor containing/consisting of sequence(s) and 5’-lCs.dAs.lCs.dGs.dAs.lTs.lTs.dAs.lGs.lCs.dAs.lTs.lTs.lA-3’ (SEQ ID NO: 53), where l is a closed nucleotide; d is a deoxyribonucleotide; s is a phosphorothioate linkage.

EFFECT: invention can be used for treating a malignant tumour, such as T-cell lymphoma; and can also be used to reduce or inhibit malignant T-cell proliferation.

34 cl, 28 dwg, 14 tbl, 13 ex

Similar patents RU2718534C2

Title Year Author Number
VERSIONS OF RECOMBINANT AAV AND USE THEREOF 2015
  • Flotte, Terence
  • Xie, Jun
  • Gao, Guangping
RU2738421C2
SET OF OLIGODEOXYRIBONUCLEOTIDE PRIMERS FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT BASED ON BIOMOLECULAR MARKER microRNA hsa-miR-143-5p BY QUANTITATIVE PCR AND USE THEREOF 2025
  • Markin Aleksandr Mikhailovich
  • Kalmykov Vladislav Andreevich
  • Shishparenok Aleksandr Aleksandrovich
  • Khovantseva Uliana Sergeevna
  • Kiseleva Diana Gennadevna
  • Gladysheva Nadezhda Pavlovna
  • Markina Iuliia Vladimirovna
RU2838258C1
RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-143-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT 2025
  • Markin Aleksandr Mikhailovich
  • Kalmykov Vladislav Andreevich
  • Shishparenok Aleksandr Aleksandrovich
  • Gladysheva Nadezhda Pavlovna
  • Khovantseva Uliana Sergeevna
RU2837872C1
PHARMACEUTICAL COMPOSITION COMPRISING microRNA-100 AND USE THEREOF IN MODULATING GROWTH OF BLOOD VESSELS AND ENDOTHELIUM INFLAMMATION 2010
  • Zebastian Grundmann
  • Martin Mozer
  • Kristof Bode
  • Frantsiska Blum
  • Feliks Khans
RU2586531C2
METHOD FOR PREDICTION OF RECURRENT MISCARRIAGE BY MICRORNA GENE EXPRESSION IN ENDOMETRIAL BIOPSY MATERIAL 2025
  • Shakhpazian Nikolai Konstantinovich
  • Mikhaleva Liudmila Mikhailovna
  • Sadykhov Nikolai Kiazimovich
  • Gioeva Zarina Vladislavovna
  • Mikhalev Sergei Aleksandrovich
  • Kurtser Mark Arkadevich
  • Radzinskii Viktor Evseevich
  • Orazov Mekan Rakhimberdyevich
RU2837879C1
DOUBLE TARGETING OF NUCLEOTIDE SEQUENCES MIR-208 AND MIR 499 IN TREATING CARDIAC DISEASES 2010
  • Olson Ehrik
  • Ruidzh Eva Van
RU2515926C2
ONCOLYTIC VIRAL VECTORS AND THEIR APPLICATION 2018
  • Finer, Mitchell H.
  • Lerner, Lorena
  • Queva, Christophe
  • Kennedy, Edward
RU2771110C2
ANTICANCER RNA VACCINES 2017
  • Valiante, Nicholas
  • Ashburn, Ted
  • Hopson, Kristen
RU2768829C2
RECOMBINANT PLASMID DNA CODING microRNA hsa-miR-145-5p, AND ITS USE AS POSITIVE CONTROL IN REAL-TIME PCR FOR DIAGNOSING CARDIOVASCULAR DISEASES AND DETECTING RISK OF THEIR DEVELOPMENT 2025
  • Markin Aleksandr Mikhailovich
  • Kalmykov Vladislav Andreevich
  • Shishparenok Aleksandr Aleksandrovich
  • Gladysheva Nadezhda Pavlovna
  • Khovantseva Uliana Sergeevna
RU2837874C1
OLIGODENDROCYTE-SPECIFIC PROMOTOR, microRNA SPECIFIC TO PLP1 GENE, VECTOR CONTAINING SPECIFIED PROMOTOR AND/OR SPECIFIED microRNA, AND PHARMACEUTICAL COMPOSITION CONTAINING SPECIFIED VECTOR 2019
  • Inoue Ken
  • Li Heng
  • Okada Takashi
  • Ohki Yu
  • Koizumi Makoto
RU2788605C2

RU 2 718 534 C2

Authors

Rodman, David

Seto, Anita

Dalby, Christina

Jackson, Aimee

Beatty, Xuan

Dates

2020-04-08Published

2016-06-03Filed